About Us

We Care About Making
Better Therapeutics

Solving complex problems to meet patients’ needs is our mission—caring deeply about client programs is our nature

BIOVECTRA is a North American CDMO specializing in clinical-to-commercial scale production capabilities for:

  • Biologics
  • Synthetic small molecules
  • pDNA and mRNA
  • Highly potent APIs
  • Bioreagents

Our teams, backed by 50+ years of experience and a proven track record of excellence, optimize, adapt, and perfect innovative technologies and drug substance development approaches to deliver world-class solutions for pharmaceutical manufacturing.

We thrive on the vexing challenges few CDMOs would have the expertise or desire to address. Bold vision, along with the passion and commitment to make that vision a reality, is at the heart of our organization.

We care. We care about your projects. We care about quality. We care about innovation. We care about high quality pharmaceutical manufacturing.

Our Team Cares About Your Success

Flexibility, creativity, and dedication to process optimization are at the heart of our work. This is reflected in our method and process development, quality, and compliance efforts. We ensure that programs advance on time and with the highest quality outcomes under our leadership.

“Flexibility is built into our DNA. The ability and dedication to solving our clients’ complex problems, no matter what it takes, is the key to our long-term relationships.”

— Andrew Mitchell, Senior Director Business Development

BIOVECTRA in Numbers


Years of experience


Active clients across five geographic markets


Top pharma and biotech companies supported


Partnered capacity expansion projects since 2003